Found 25 matching trials
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
PHASE2Purpose: The aim of this clinical trail is to evaluate Tetrathiomolybdate (...
Location
The University of Michigan Comprehensive Cancer Center
Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840
PHASE2The main objective of the study is to evaluate the change in liver copper (...
Study of Tetrathiomolybdate in Patients With Wilson Disease
PHASE3OBJECTIVES:
Evaluate the safety and efficacy of ammonium tetrathiomolybdat...
Location
University of Michigan
Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
PHASE3The University of Michigan is conducting a study investigating a potential ...
Location
University of Michigan
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
PHASE2RATIONALE: Exemestane may stop the growth of tumor cells by blocking some o...
Location
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
PHASE2Surgery has been the standard of care for esophageal cancer for many years,...
Location
University of Michigan Cancer Center
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
PHASE1This is a Phase 1, randomized, 2-period, 2-sequence, cross-over study desig...
Location
Clinical Trial Site
Early Access Program for ALXN1840 in Patients With Wilson Disease
N/AThis is an open-label, single-arm, multi-center EAP, designed to provide ea...
Status
No Longer Available
Location
Multiple Locations
Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
PHASE1This study will evaluate the safety of the administration of a copper chela...
Location
University of Michigan Health System
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
PHASE1There are two parts to this study. It is a phase 1b followed by a randomize...
Location
Indiana University Simon Cancer Center